Profusa PFSA 深 滬
等待開盤 10-08 09:30:00 美东时间
1.50
-0.160
-9.64%
華盛通- 最 高1.68
- 今 開1.62
- 成交量 42.41万股
- 最 低 1.42
- 昨 收 1.66
- 總市值 90.85万
- 52周最高 3000.00
- 市盈率 靜 --
- 換手率 70.03%
- 52周最低 1.42
- 委 比 -9.71%
- 總股本 60.56万
- 歷史最高 18000.00
- 量 比 0.77
- 振 幅 15.66%
- 歷史最低 1.42
- 每 手 1
- 風險率 696.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Profusa Amends Convertible Notes and Financing Terms
The latest update is out from Profusa ( ($PFSA) ). On October 4, 2026, Profusa ...
10-05 18:29
Profusa shares are trading higher after the company announced it received a positive decision from GMED regarding certification of its quality management system to ISO 13485.
Profusa shares are trading higher after the company announced it received a positive decision from GMED regarding certification of its quality management system to ISO 13485.
09-24 20:49
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
Profusa, Inc. has received a positive decision from GMED for ISO 13485 certification of its quality management system, supporting the Lumee® Oxygen Platform's MDR conformity assessment. The company is progressing toward CE marking, indicating compliance with EU safety and health standards. The Lumee platform enables continuous tissue oxygen monitoring, aiding clinical decision-making. Profusa continues to work with GMED to complete remaining MDR ...
09-24 11:30
Profusa Adds Secured Convertible Debt Financing Agreement
The latest announcement is out from Profusa ( ($PFSA) ). On September 16, 2026,...
09-16 18:42
Profusa clears Nasdaq compliance issues
Profusa (PFSA) said it has regained compliance with Nasdaq’s minimum bid price and equity requirements. However, it will remain subject to a one-year mandatory Nasdaq monitoring period. If it fails to...
09-15 19:22
Profusa, Inc. Receives Nasdaq Compliance Determination
Profusa, Inc. announced compliance with Nasdaq's Bid Price and Equity Rules, receiving a Compliance Determination Letter. The company is under a one-year Mandatory Panel Monitor. If it fails to meet the Equity Rule during this period, Nasdaq may delist it without allowing a compliance plan submission. Profusa intends to continue monitoring its compliance. The company is a digital health firm and has signed an option agreement to potentially acqui...
09-15 10:00
Profusa Confirms Continued Compliance With Nasdaq Listing Standards
Profusa ( ($PFSA) ) has issued an update. On August 26, 2026, Profusa disclosed...
08-31 21:54
Profusa regains Nasdaq compliance; shares up
Profusa (PFSA) received a Nasdaq notice stating it had fallen below the 500,000 publicly held shares requirement after its 1-for-4 reverse stock split on August 14, 2026. PFSA shares up 6.8% premarket...
08-31 21:10
Profusa, Inc. reports Q2 results
Profusa, Inc. press release (PFSA): Q2 Cash on hand at June 30, 2026 was $719,000. Total assets were $1.0 million. Current liabilities and total liabilities were $28.2 million. Net loss for the three ...
08-21 03:10
Profusa Q2 EPS $(151.80) Up From $(9.10 thousand) YoY
Profusa (NASDAQ:PFSA) reported quarterly losses of $(151.80) per share. This is a 98.33 percent increase over losses of $(9.10 thousand) per share from the same period last year.
08-20 20:53
